Cbay stock forecast.
Analyst projections state that BYND is forecast to be at a low of $3.00 and a high of $9.00. In order for the stock price to hit the forecast high, the stock would need to plunge -39.32% from its current level, while the stock would need to crash 53.56% from its current level to reach the projected low. Beyond Meat Inc (BYND) estimates and ...
In a recent transaction on November 17, 2023, Charles Mcwherter, the President of Research and Development at CymaBay Therapeutics Inc (NASDAQ:CBAY), sold 11,342 shares of the company's stock ... CymaBay Therapeutics Stock Forecast and Price Target. If CymaBay Therapeutics's stock price reached the average yearlong target of $10.00 given by five well-known analysts in recent months, there would be a potential downside of approximately -18.57% from its last closing price in July, 2023.CBAY stock showed promising performance on November 8, 2023, according to data from CNN Money. The 12 analysts offering 12-month price forecasts for CymaBay Therapeutics Inc had a median target of 22.50, with a high estimate of 33.00 and a low estimate of 19.00.A price increase of 4.9% over the past four weeks ensures that the trend is still in place for the stock of this company. Moreover, CBAY is currently trading at 82.5% of its 52-week High-Low Range ...há 4 dias ... For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, ...
The latest CymaBay Therapeutics stock prices, stock quotes, news, and CBAY history to help you invest and trade smarter. ... The 29 analysts offering price forecasts for CymaBay Therapeutics have ...3 Wall Street analysts have issued twelve-month target prices for Aldeyra Therapeutics' shares. Their ALDX share price targets range from $8.00 to $15.00. On average, they expect the company's share price to reach $12.33 in the next year. This suggests a possible upside of 370.7% from the stock's current price.Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Viking Therapeutics Inc have a median target of 34.00, with a high estimate of 40.00 and a low estimate of 28.00. The ...
Predictions of CBAY stock price for tomorrow. 14-day Premium Trial Subscription Try For Free Get FreeCBAY stock showed promising performance on November 8, 2023, according to data from CNN Money. The 12 analysts offering 12-month price forecasts for CymaBay Therapeutics Inc had a median target of 22.50, with a high estimate of 33.00 and a low estimate of 19.00.
According to analyst projections, CBAY’s forecast low is $20.00 with $34.00 as the target high. To hit the forecast high, the stock’s price needs a -82.21% plunge from its current level, while the stock would need to soar -7.18% for it to hit the projected low. Cymabay Therapeutics Inc (CBAY) estimates and forecasts1,785.90 +6.50(+0.37%) Crude Oil (+0.21%) Advertisement CymaBay Therapeutics, Inc. (CBAY) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M …ETNB Stock 12 Months Forecast. Based on 9 Wall Street analysts offering 12 month price targets for 89bio in the last 3 months. The average price target is $31.38 with a high forecast of $39.00 and a low forecast of $25.00. The average price target represents a 271.36% change from the last price of $8.45.The current CymaBay Therapeutics [ CBAY] share price is $17.90. The Score for CBAY is 74, which is 48% above its historic median score of 50, and infers lower risk than normal. CBAY is currently trading in the 70-80% percentile range relative to its …NEWARK, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic ...
Of course, the risk is real, too; not every penny stock is going to show th Risk and reward are the yin and yang of stock trading, the two opposite but essential ingredients in every market success.
CymaBay Therapeutics Inc. 18.65. Delayed Data. As of Nov 20. +0.30 / +1.63%. Today’s Change. 3.17. Today ||| 52-Week Range. 18.81.
Sep 8, 2023 · He kept his outperform rating on CBAY stock and raised his price target to 20 from 18. Notably, CymaBay stock has a best-possible Relative Strength Rating of 99, according to IBD Digital. This ... Nov 29, 2023 · Future criteria checks 2/6. CymaBay Therapeutics is forecast to grow earnings and revenue by 47.6% and 61.6% per annum respectively. EPS is expected to grow by 45.7% per annum. Return on equity is forecast to be -57.1% in 3 years. Find the latest Absci Corporation (ABSI) stock quote, history, news and other vital information to help you with your stock trading and investing.The consensus price target of analysts on Wall Street is $24.42, which implies an increase of 21.66% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $20.00 and $34.00 respectively. As a result, CBAY is trading at a discount of -77.73% off the target high and -4.55% off the low.SPRB Stock 12 Months Forecast. $8.40. (510.91% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Spruce Biosciences in the last 3 months. The average price target is $8.40 with a high forecast of $10.00 and a low forecast of $7.00. The average price target represents a 510.91% change from the last price of $1.38.
Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Swvl Holdings Corp have a median target of 37.50, with a high estimate of 37.50 and a low estimate of 37.50. The median ...As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.Their CBAY share price targets range from $12.00 to $34.00. On average, they expect the company's stock price to reach $22.27 in the next twelve months. This suggests a possible upside of 13.0% from the stock's current price. View analysts price …According to CBAY; 1 in 1,000 women over the age of 40 live with PBC. Interested in CymaBay stock? Get a free CBAY Stock Research Report. Atara Bio (ATRA) Source: Shutterstock.Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...
Forecast . Price target. 24.08 0.00 0.00%. The 12 analysts offering 1 year price forecasts for CBAY have a max estimate of — and a min estimate of —. Analyst rating. Based on 13 analysts giving stock ratings to CBAY in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreDec 1, 2023 · CymaBay Therapeutics (CBAY) Stock Price, News & Analysis $17.90 -0.21 (-1.16%) (As of 11/22/2023 ET) Compare Today's Range $17.82 $18.45 50-Day Range $12.63 $18.66 52-Week Range $3.21 $19.06 Volume 1.15 million shs Average Volume 1.89 million shs Market Capitalization $2.03 billion P/E Ratio N/A Dividend Yield N/A Price Target $22.27
1,785.90 +6.50(+0.37%) Crude Oil (+0.21%) Advertisement CymaBay Therapeutics, Inc. (CBAY) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M …CymaBay Therapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of proprietary new medicines for important human diseases. The Company's lead ...Stock Price Forecast. The 12 analysts offering 12-month price forecasts for CymaBay Therapeutics Inc have a median target of 22.00, with a high estimate of 33.00 and a low estimate of 19.00. The median estimate represents a +76.85% increase from the last price of 12.44.Sep 8, 2023 · CymaBay (CBAY) Stock Up on Positive Results From PBC Study. ... The median home sale price will fall 1.7% next year after eking out an anticipated 0.2% gain in 2023, according to the forecast. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Nov 29, 2023 · Predictions of CBAY stock price for tomorrow. 14-day Premium Trial Subscription Try For Free Get Free
A high-level overview of eBay Inc. (EBAY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
CBAY Signals & Forecast. Mostly positive signals in the chart today. The Cymabay Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average.
CBAY stock has been performing well according to 12 analysts offering 12-month price forecasts. The median target price is $22.50, with a high estimate of $33.00 and a low estimate of $19.00. This indicates a potential increase of 37.95% from the last recorded price of $16.31. The consensus among 13 polled investment analysts is to buy stock in ...há 6 dias ... ... CBAY's share price rises to $24.00, which is the median consensus price. At that level, CBAY's share price would be -31.87% below current price.NextPlay Technologies, Inc. (NASDAQ:NXTP) announced its quarterly earnings results on Wednesday, January, 12th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by $0.02. The firm earned $4.20 million during the quarter, compared to the consensus estimate of $5.70 million.A price increase of 4.9% over the past four weeks ensures that the trend is still in place for the stock of this company. Moreover, CBAY is currently trading at 82.5% of its 52-week High-Low Range ...Based on short-term price targets offered by 11 analysts, the average price target for CymaBay Therapeutics Inc. comes to $24.45. The forecasts range from a low of $20.00 to a high of $34.00.CymaBay Therapeutics Inc (CBAY) stock is trading at $11.76 as of 11:26 AM on Monday, Jul 3, a rise of $0.81, or 7.39% from the previous closing price of $10.95. The stock has traded between $10.95 and $11.77 so far today. Volume today is low. So far 1,522,720 shares have traded compared to average volume of 2,310,531 shares.If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Get the latest CymaBay Therapeutics Inc (CBAY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Nov 14, 2023 · CymaBay Therapeutics Stock Forecast 2023. In the last five quarters, CymaBay Therapeutics’s Price Target has fallen from $29.28 to $23.09 - a -21.14% decrease. Five analysts predict that CymaBay Therapeutics’s share price will fall in the coming year, reaching $10.00. This would represent a decrease of -56.69%. LifeSci Capital analyst Patrick Dolezal has maintained their bullish stance on CBAY stock, giving a Buy rating yesterday. Patrick Dolezal has given his Buy rating due to a combination of factors ...TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comStock Price Forecast The 6 analysts offering 12-month price forecasts for Aldeyra Therapeutics Inc have a median target of 9.00, with a high estimate of 11.00 and a low estimate of 7.00.
The stock is selling for $9.87 and its $13.89 average price target suggests a 12-month upside potential of ~41%. (See CBAY stock forecast ) Cerevel Therapeutics ( CERE )Dec 1, 2023 · 3 Wall Street research analysts have issued 1-year price targets for Tecnoglass' shares. Their TGLS share price targets range from $43.00 to $54.00. On average, they anticipate the company's stock price to reach $48.20 in the next year. This suggests a possible upside of 30.2% from the stock's current price. Sector. Consumer Non-Durables. Industry. Food: Specialty/Candy. No executives to display. Corporate headquarters. --, --. Find real-time BROS - Dutch Bros Inc stock quotes, company profile, news ...Cymabay Therapeutics Inc (NASDAQ:CBAY) trade information. Instantly CBAY has been showing red trend so far today with a performance of -1.24% on intraday trading today. The performance over the last five days has remained in the red territory. The company’s shares are currently up 186.68% year-to-date, but still down -3.67% over the last five ...Instagram:https://instagram. nyse stock exchange holidaysbest mortgage lenders for self employedbtcxex dividend schedule CBAY 8.19%. 70. See CBAY Report. CymaBay Therapeutics Inc ( CBAY) is near the top in its industry group according to InvestorsObserver. CBAY gets an overall rating of 80. That means it scores higher than 80 percent of stocks. CymaBay Therapeutics Inc gets a 91 rank in the Biotechnology industry. Biotechnology is number 13 out of 148 … demo forexno load index funds See the latest CymaBay Therapeutics Inc stock price (CBAY:XNAS), related news, valuation, dividends and more to help you make your investing decisions. CBAY Stock Price Quote | Morningstar...AC Immune S.A. analyst ratings, historical stock prices, earnings estimates & actuals. ACIU updated stock price target summary. pre ipo platform People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Track Cymabay Therapeutics Inc (CBAY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsThe CymaBay Therapeutics stock forecast for tomorrow is $ 19.01, which would represent a -0.48% loss compared to the current price. In the next week, the price of CBAY is expected to decrease by -5.95% and hit $ 17.96. As far as the long-term CymaBay Therapeutics stock forecast is concerned ...